Latest Development Pipeline News

HMC Capital has unveiled an ambitious plan to grow its assets under management to over $50 billion within the next 3-5 years, supported by strong fundraising and diversified investment verticals. The company’s FY25 outlook remains solid, underpinned by operational growth and strategic initiatives across real estate, digital infrastructure, and energy transition.

GPT Group unveiled a strategic pivot towards co-investment alongside capital partners, reporting resilient 2024 earnings and expanding its retail management platform through key partnerships and asset acquisitions.

Recce Pharmaceuticals reports strong Phase II clinical trial results for its topical anti-infective R327G, achieving a 93% efficacy rate in treating ABSSSI, alongside a significant capital raise to fund upcoming Phase III trials.

GTI Energy reports positive uranium leach test results at its Lo Herma ISR Uranium Project, confirming mineralisation amenable to alkaline in-situ leach with recoveries around 75%. The company’s scoping study is on track for Q2 2025, supported by updated resource estimates and hydrogeological data.

MPower Group has completed a pivotal equity conversion of its Narromine Renewable Energy Project, extinguishing $10.36 million in project funding and positioning itself for a $700,000 gain. The company also secured additional financing and advanced its renewable energy pipeline amid ongoing operational challenges.

AustChina Holdings has completed a strategic placement raising $412,500 to fund exploration of newly acquired gold and antimony prospects in Tasmania, marking a key step in its resource expansion strategy.

QMines Limited reports a 42% increase in Indicated resources at Develin Creek following maiden drilling, completes a $4 million capital raise, and moves to acquire the Mount Mackenzie gold-silver project, signaling a strategic expansion in Queensland.

Noxopharm Limited has successfully cleared key preclinical hurdles for its SOF-SKN™ lupus drug and expanded its Sofra™ platform collaborations, supported by fresh funding to propel upcoming clinical trials.

Mirvac Group reported a surge in residential sales and advanced capital partnerships for major developments, reaffirming its FY25 earnings guidance amid strong leasing and occupancy across its portfolio.

Stockland’s 3Q25 update highlights steady progress on its Waterloo Renewal Project and solid sales in masterplanned communities, supporting maintained FY25 earnings guidance.

Blue Star Helium has commenced drilling the Jackson 2 well at its Galactica helium project in Colorado, marking a key step in its ongoing development program. The well is progressing towards the Lyons Formation target with plans for flow testing and production tie-in.

Elevate Uranium Ltd reports steady progress on its U-pgrade demonstration plant and ongoing exploration drilling at Koppies and Marenica projects, alongside a 12% resource increase at the Bigrlyi Joint Venture and the appointment of a new chairman.